J1170 HCPCS code: Injection, hydromorphone, up to 4 mg
J1170 is the HCPCS Level II code for injection, hydromorphone, up to 4 mg. CMS terminated J1170 on 2024-09-30; do not bill it for later dates of service. In 2024 Medicare paid an average of $2.78 per service for J1170 across 162,172 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. Medicare volume fell 34% from 2022 to 2024 (245,939 to 162,172 services). In 2024, 21 suppliers billed Medicare for J1170 (purchases), serving 31 beneficiaries; Maryland, Maine, California accounted for 76% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 2024-10-01 |
| Terminated | 2024-09-30 |
Who bills J1170 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 21 |
| Referring clinicians | 51 |
| Medicare beneficiaries | 31 |
| States with claims | 7 |
| Share of services in top 3 states (Maryland, Maine, California) | 76% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 40 | 69 |
| 2023 | 25 | 41 |
| 2024 | 21 | 31 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1170, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 245,939 | 3,342 | $2.78 | $2.17 |
| 2023 | 233,527 | 3,171 | $3.56 | $2.80 |
| 2024 | 162,172 | 2,668 | $3.56 | $2.78 |
States with the most J1170 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Kentucky | 40,321 | $2.98 |
| California | 24,706 | $2.64 |
| Florida | 22,982 | $3.03 |
| Pennsylvania | 15,494 | $2.52 |
| Arizona | 10,929 | $2.17 |
What changed for J1170
- 1982-01-01: J1170 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1170?
J1170 is the HCPCS Level II code for injection, hydromorphone, up to 4 mg. Short descriptor: "Hydromorphone injection".
How much does Medicare pay for J1170?
In 2024, the average Medicare payment was $2.78 per service (average allowed $3.56).
Does Medicare cover J1170?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J11 codes
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg
- J1105 — Dexmedetomidine, oral, 1 mcg
- J1110 — Injection, dihydroergotamine mesylate, per 1 mg
- J1120 — Injection, acetazolamide sodium, up to 500 mg
- J1130 — Injection, diclofenac sodium, 0.5 mg
- J1160 — Injection, digoxin, up to 0.5 mg
- J1162 — Injection, digoxin immune fab (ovine), per vial
- J1163 — Injection, diltiazem hydrochloride, 0.5 mg
- J1164 — Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165 — Injection, phenytoin sodium, per 50 mg
- J1171 — Injection, hydromorphone, 0.1 mg
- J1180 — Injection, dyphylline, up to 500 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1170
- Watch J1170 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1170
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.